This is a community-generated profile. If you would like to claim it, please .
Discovering and developing new cellular immunotherapies for cancer
UNUM Therapeutics Funding
$0
22 rounds
UNUM Therapeutics has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on June 12, 2015.
Funding Rounds
B
$65000000Series BJun 2015
+3
U
$12000000Investors of UNUM Therapeutics
Cowen Group
F-Prime
Sabby Management
Square 1 Bank
Seattle Genetics
Rounds
B
Novo A/S
Rounds
B
Jennison Associates
Rounds
B
Sectoral Asset Management
Rounds
B
Wellington Management
Investment management across global public and private markets
Rounds
B